FACIAL REJUVENATION MARKET ANALYSIS

Facelifts, sometimes referred to as rhytidectomy, are occasionally necessary to treat sagging face skin. A facelift can be achieved using a variety of ways. Eyelid rejuvenation can be done concurrently with or before a face and neck lift.

Global facial rejuvenation market is estimated to be valued at US$ 24,616.7 million in 2022 and is expected to exhibit a CAGR of 7.7 % during the forecast period (2022-2030).

Figure 1. Global Facial Rejuvenation Market Share (%), by Region, 2022

To learn more about this report, request a free sample copy

Increasing product launch and approvals for facial rejuvenation are expected to drive growth of the facial rejuvenation market.

Increasing product launch and approvals for facial rejuvenation are expected to drive growth of the facial rejuvenation market. For instance, in May 2022, The U.S. Food and Drug Administration (FDA) approved the Renuvion Dermal Handpiece for the treatment of moderate to severe wrinkles and rhytides, limited to patients with fitzpatrick skin types.

Figure 2. Global Facial Rejuvenation Market Share (%), by End User, 2022

To learn more about this report, request a free sample copy

Increasing approvals of technologically advancement are expected to drive market growth during the forecast period.

Increasing approvals of technologically advancement are expected to drive market growth during the forecast period. For instance, in April 2021, Alma, one of the global leaders of energy-based medical and aesthetics solutions, launched Alma PrimeXTM device, for skin tightening.

Global Facial Rejuvenation Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, faced problems with regard to the transportation of drugs and vaccines, etc. from one place to another.

However, the COVID-19 pandemic had a positive impact on the global facial rejuvenation market. During the pandemic, 11% of women surveyed in U.S. indicated they are more interested in cosmetic surgery or non-surgical procedures now than before COVID-19, and the figure is even higher among women who have already had surgery or a procedure – 24%, respectively. Moreover, 35% of women who have previously had at least one cosmetic surgical procedure or minimally invasive procedure plan to spend significantly or somewhat more on treatments in 2021 than in 2020.

Global Facial Rejuvenation Market: Key Developments

Key players in the market are focused on establishing subsidiaries to expand their geographical presence. For instance, in October 2019, InMode Ltd. which is global provider of innovative, radiofrequency minimally and non-invasive medical technology, completed the establishment of two new subsidiaries in Asia Pacific - InMode India and InMode Australia.

In December 2019, Daewoong Pharmaceutical, a pharmaceutical company based in South Korea, received approval for its botulinum toxin product, Nabota, from The Ministry of Health in the U.A.E. and Indonesia’s Badan Pengawas Obat dan Makanan.

Global Facial Rejuvenation Market: Restraint

The major factors that hinder growth of the global facial rejuvenation market include high cost of facial rejuvenation procedures. For instance, according to American Society of Plastic Surgeons (ASPS), the average cost of intense pulsed light (IPL) treatment is US$ 412 and the average cost of nonsurgical skin tightening is US$ 2,456.

Key Players

Major players operating in the global facial rejuvenation market include Merz Pharma, Anika Therapeutic, Lumenis, Galderma, Allergan (Actavis), Contura Ltd,Fibrocell ScienceInc., Revance Therapeutics, Cynosure, Lumenis, Bausch Health Companies Inc., Alma Lasers ,STRATA Skin Sciences, LUTRONIC ,Sciton, Inc.